And a little more:
“Pulmatrix Inc (NASDAQ:PULM) And Its Partner Sensory Cloud Announce FEND’s Commercial Rollout”
” that FEND’s commercial launch is an important milestone for his company because it will help to combat the coronavirus pandemic more effectively.”
A pandemic their Respiratory and Allergy Expert appointed to their Scientific Advisory Board states isn’t happening….?
” They are optimistic that FEND will not only help to reduce the spread of the coronavirus but that it will help to make a notable impact in fighting against the pandemic at a global scale. Pulmatrix also expects to receive royalties from Sensory Cloud as part of their distribution agreement.”
What’s going on?